RT

Relmada Therapeutics

RLMD

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-83.89M

EBITDA$-79.98M

EBIT$-79.98M

Pre-tax Income$-58.88M

Net Income$-79.98M

Balance Sheet

Cash Equivalent$2.19M

Total Debt$0

Book Value$54.17M

Book Value Per Share1.80

Key Ratios

Return on Equity (ROE)-225.15%

Return on Assets (ROA)-174.56%

Return on Invested Capital (ROI)-225.15%

Net Profit Margin-500.00%

Current Ratio4.45

Quick Ratio4.36

Long-Term Debt / Equity0.00